Pharmafile Logo

VJOncology

- PMLiVE

Mallinckrodt doses first patient in muscular dystrophy trial

Repurposed drug could help delay decline in muscle function

- PMLiVE

China’s BeiGene raises $903m from Hong Kong IPO

Mammoth debut might have exceeded $1bn but for market jitters

New ICMJE Guidelines and their Impact on Biotech

Currently, and over the past several years, I have enjoyed working with smaller biotechnology and pharma companies, many of which are looking to bring their first product to market. These...

Porterhouse Medical Group

- PMLiVE

Healthcare Comms round up

JOLT and The Ideas Foundation share talent fund, Ashfield opens new office and The Difference Collective offers charitable services

Daiichi Sankyo logo

Daiichi gets breakthrough status for pre-NDA leukaemia drug

Quizartinib could have an advantage over rival drug Rydapt

- PMLiVE

Trust me, I’m from pharma

Chris Ross, with the help of five industry thought leaders, explores how the industry can enhance its public reputation by focusing on making a difference – rather than just making...

- PMLiVE

EMA cuts back as Brexit staff losses top expectations

Regulator says it faces loss of 30% of staff

- PMLiVE

Immunology keeps Shire figures solid as Takeda takeover nears

Shire’s sales increased by 6% to $3.81bn

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links